Sponsors

Tepnel extends licence agreement with Luminex

Tepnel Life Sciences has agreed an extension of the licence with Luminex for access to the Luminex xMAP platform. The Luminex xMAP technology is incorporated in TepnelÆs innovative molecular diagnostics products.

Tepnel’s LifeMatch products are used for the measurement and detection of human leucocyte antigen (HLA) markers, which are used in the field of bone marrow and solid organ transplantation. These products permit the rapid analysis of a donor’s HLA type to determine if they are a potential match to a patient awaiting transplantation.

Tepnel develops highly multiplexed DNAand protein-based assays and user-friendly software for its successful LifeMatch product line. The Luminex technology allows Tepnel Lifecodes users to analyse up to 100 simultaneous reactions on a single patient sample.

www.tepnel.com

Latest Issues

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026